Gonzalo Rodriguez-Berriguete

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Helicobacter Pylori

Immune Response

Top Venues

Cell death & disease

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M Buffa, Kevin J Harrington, Geoff S Higgins
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease 15 (1) (2024)
Gonzalo Rodriguez-Berriguete, Marco Ranzani, Remko Prevo, Rathi Puliyadi, Nicole D Machado, Hannah R Bolland, Val Millar, Daniel V Ebner, Marie Boursier, Aurora Cerutti, Alessandro Cicconi, Alessandro Galbiati, Diego Grande, Vera Grinkevich, Jayesh Majithiya, Desiree Piscitello, Eeson Rajendra, Martin Stockley, Simon J Boulton, Eva-Leonne Göttgens, Robert A Heald, Graeme C M Smith, Helen M R Robinson, Geoff S Higgins
Small-molecule Polθ inhibitors provide safe and effective tumor radiosensitization in preclinical models. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Gonzalo Rodriguez-Berriguete, Marco Ranzani, Remko Prevo, Rathi Puliyadi, Nicole D Machado, Hannah R Bolland, Val Millar, Daniel V Ebner, Marie Boursier, Aurora Cerutti, Alessandro Cicconi, Alessandro Galbiati, Diego Grande, Vera Grinkevich, Jayesh Majithiya, Desiree Piscitello, Eeson Rajendra, Martin Stockley, Simon J Boulton, Eva-Leonne Göttgens, Robert A Heald, Graeme C M Smith, Helen M R Robinson, Geoff S Higgins
Small-molecule Polθ inhibitors provide safe and effective tumor radiosensitization in preclinical models. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)